MARGARET H DUGAN
Medical Practice in Flushing, NY
License number
New Jersey 25MA04974600
Issued Date
Apr 23, 1987
Expiration Date
Jun 30, 1993
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Flushing, NY
Personal information
See more information about MARGARET H DUGAN at radaris.comName
Address
Phone
508 Meeker Rd, Vestal, NY 13850
5 Rose Garden Ct APT 11, Latham, NY 12110
4442 64Th St, Woodside, NY 11377
390 Winona Blvd, Rochester, NY 14617
42 Camille Dr, Rochester, NY 14612
Professional information
Combination Comprising A Vasculostatic Compound And An Alkylating Agent For The Treatment Of A Tumor
US Patent:
7754716, Jul 13, 2010
Filed:
Jun 27, 2003
Appl. No.:
10/518989
Inventors:
Margaret Han Dugan - Woodside NY, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/502, C07D 401/06, C07D 487/04, A61K 31/33
US Classification:
514248, 544237, 544179, 514183
Abstract:
The invention relates to a pharmaceutical combination which comprises (a) a vasculostatic compound, (b) an alkylating agent and (c) optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use for the treatment of a tumor disease; a pharmaceutical composition comprising such a combination; the use of such a combination for the preparation of a medicament for the treatment of a tumor disease; a commercial package or product comprising such a combination as a combined preparation for simultaneous, separate or sequential use; and to a method of treatment of a warm-blooded animal, especially a human.
Method For Treating Pediatric High Grade Astrocytoma Including Brain Stem Glioma
US Patent:
5942247, Aug 24, 1999
Filed:
Jul 29, 1997
Appl. No.:
8/902381
Inventors:
Margaret H. Dugan - Woodside NY
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3133
US Classification:
424451
Abstract:
There is disclosed a method for treating high grade astrocytoma, especially brain stem glioma, in a child by administering to a child in need of such treating an amount of temozolomide sufficient to achieve a clinical response. Preferred dosing schedules are provided.
Dr. Margaret H Dugan, Woodside NY - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
4442 64Th St, Woodside 11377
(718) 478-8431 (Phone)
(718) 478-8431 (Phone)
Certifications:
Hematology, 1986, Internal Medicine, 1984, Medical Oncology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York University
Graduated: 1981
Manhatten Va Hosp
Nyc Med Ctr
Nyu Langone Medical Center
New York University
Graduated: 1981
Manhatten Va Hosp
Nyc Med Ctr
Nyu Langone Medical Center
Use Of 4-Pyridylmethylphthalazines For Cancer Treatment
US Patent:
2009019, Aug 6, 2009
Filed:
Apr 15, 2009
Appl. No.:
12/423843
Inventors:
Margaret Han DUGAN - Woodside NY, US
Jeanette Marjorie WOOD - Biel-Benken, CH
Jeanette Marjorie WOOD - Biel-Benken, CH
International Classification:
A61K 39/395, A61K 31/502, A61P 35/00
US Classification:
4241331, 514248
Abstract:
Patients suffering from renal carcinoma are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agent. Patients having different tumor types, e.g. renal cancer, are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agent while undergoing chemotherapy.
Combination Therapy (Temozolomide And Alpha-Ifn) For Advanced Cancer
US Patent:
2008005, Mar 6, 2008
Filed:
Nov 5, 2007
Appl. No.:
11/935083
Inventors:
Margaret Dugan - Woodside NY, US
International Classification:
A61K 38/21, A61P 35/00
US Classification:
424085700
Abstract:
There is disclosed a method for treating advanced cancer in patients in need of such treating. Temozolomide and alpha interferon are administered in combination in amounts sufficient to achieve a clinical response.
Use Of 4-Pyridylmethyl-Phthalazine Derivatives For The Manufacture Of A Medicament For The Treatment Of Myelodysplastic Syndromes
US Patent:
2006012, Jun 15, 2006
Filed:
Sep 23, 2003
Appl. No.:
10/528914
Inventors:
Margaret Dugan - Woodside NY, US
Alan List - Tucson AZ, US
Alan List - Tucson AZ, US
International Classification:
A61K 31/501
US Classification:
514252030, 514252040
Abstract:
The present invention relates to a method of treating myelodysplastic syndromes comprising administering a therapeutically effective amount of a 4-pyridylmethyl-phthalazine derivative to a warm-blooded animal in need thereof.
Use Of 4-Pyridylmethylphthalazines For Cancer Treatment
US Patent:
2004025, Dec 23, 2004
Filed:
Aug 5, 2004
Appl. No.:
10/489751
Inventors:
Margaret Dugan - Woodside NY, US
Jeanette Wood - Biel-Benken, CH
Jeanette Wood - Biel-Benken, CH
International Classification:
A61K031/50, A61K031/525, A61K033/24
US Classification:
424/649000, 514/248000, 514/050000, 514/251000
Abstract:
Patients suffering from renal carcinoma are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agents. Patients having different tumor types, e.g. renal cancer, are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agent while undergoing chemotherapy.
Combination Therapy (Temozolomide And Α-Ifn) For Advanced Cancer
US Patent:
7294332, Nov 13, 2007
Filed:
Apr 26, 2002
Appl. No.:
10/134183
Inventors:
Margaret H. Dugan - Woodside NY, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 38/21, A61K 38/19
US Classification:
424 857, 424 854
Abstract:
There is disclosed a method for treating advanced cancer in patients in need of such treating. Temozolomide and alpha interferon are administered in combination in amounts sufficient to achieve a clinical response.
Combination Therapy For Advanced Cancer
US Patent:
5824346, Oct 20, 1998
Filed:
Aug 22, 1996
Appl. No.:
8/701343
Inventors:
Margaret H. Dugan - Woodside NY
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3133, A61K 3324
US Classification:
424649
Abstract:
There is disclosed a method for treating advanced cancer in patients in need of such treating. Temozolomide and cisplatin are administered in combination in amounts sufficient to achieve a clinical response.
Cancer Treatment With Temozolomide
US Patent:
5939098, Aug 17, 1999
Filed:
Jul 29, 1997
Appl. No.:
8/902380
Inventors:
Pascale Reidenberg - Westfield NJ
Margaret H. Dugan - Woodside NY
Margaret H. Dugan - Woodside NY
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3133
US Classification:
424451
Abstract:
There is disclosed a method for treating cancer in a patient in need of such treating comprising administering temozolomide in an amount sufficient to achieve a clinical response wherein the temozolomide is administered more than once per day. Preferred specific dosing schedules are provided.